RESUMEN
We have shown in a murine model system for cytomegalovirus (CMV) disease in the immunocompromised host that in vivo application of recombinant human IL-2 (rhIL-2) can enhance the antiviral effect of a limited number of CD8+T lymphocytes, not only in prophylaxis, but also in therapy, when virus has already colonized host tissues. The observed net effect of IL-2 was consistent with the assumption of daily effector population doublings. The prospects for IL-2-supported immunotherapy of established CMV infection depend upon the tissues involved in disease. It appears that the prospects for controlling established CMV adrenalitis are less promising than for a therapy of interstitial CMV pneumonia.
Asunto(s)
Infecciones por Citomegalovirus/terapia , Inmunoterapia , Interleucina-2/uso terapéutico , Animales , Infecciones por Citomegalovirus/etiología , Humanos , Inmunización Pasiva , Síndromes de Inmunodeficiencia/complicaciones , Ratones , Ratones Endogámicos BALB C , Proteínas Recombinantes/uso terapéutico , Linfocitos T/inmunología , Linfocitos T Citotóxicos/inmunologíaRESUMEN
The murine immediate-early (IE) protein pp89 is a nonstructural virus-encoded phosphoprotein residing in the nucleus of infected cells, where it acts as transcriptional activator. Frequency analysis has shown that in BALB/c mice the majority of virus-specific CTL recognize IE antigens. The present study was performed to assess whether pp89 causes membrane antigen expression detected by IE-specific CTL. Site-directed mutagenesis has been used to delete the introns from gene ieI, encoding pp89, for subsequent integration of the continuous coding sequence into the vaccinia virus genome. After infection with the vaccinia recombinant, the authentic pp89 was expressed in cells that became susceptible to lysis by an IE-specific CTL clone. Priming of mice with the vaccinia recombinant sensitized polyclonal CTL that recognized MCMV-infected cells and transfected cells expressing pp89. Thus, a herpesviral IE polypeptide with essential function in viral transcriptional regulation can also serve as a dominant antigen for the specific CTL response of the host.
Asunto(s)
Antígenos Virales/inmunología , Citomegalovirus/inmunología , Genes Virales , Proteínas Inmediatas-Precoces , Linfocitos T Citotóxicos/inmunología , Virus Vaccinia/genética , Proteínas Virales/inmunología , Animales , Antígenos Virales/genética , Infecciones por Citomegalovirus/inmunología , ADN Recombinante , ADN Viral/genética , Exones , Regulación de la Expresión Génica , Intrones , Ratones , Ratones Endogámicos BALB C , Mutación , Proteínas Virales/genéticaRESUMEN
We have established a murine model system for exploring the ability of a CD4 subset-deficient host to cope with cytomegalovirus infection, and reported three findings. First, an antiviral response of the CD8 subset of T lymphocytes could be not only initiated but also maintained for a long period of time despite a continued absence of the CD4 subset, whereas the production of antiviral antibody proved strictly dependent upon help provided by the CD4 subset. Second, no function in the defense against infection could be ascribed as yet to CD4-CD8- T lymphocytes, which were seen to accumulate to a new subset as a result of depletion of the CD4 subset. This newly arising subset did not substitute for CD4+ T lymphocytes in providing help to B lymphocytes, and was also not effective in controlling the spread of virus in host tissues. As long as a function of these cells in the generation and maintenance of a CD8 subset-mediated response is not disproved, caution is indicated with concern to an autonomy of the CD8 subset. Third, even though with delay, the CD8+ effector cells raised in the CD4 subset-deficient host were able of clear vital tissues from productive infection and to restrict asymptomatic, persistent infection to acinar glandular epithelial cells in salivary gland tissue.
Asunto(s)
Anticuerpos Antivirales/biosíntesis , Linfocitos T CD4-Positivos/inmunología , Infecciones por Citomegalovirus/inmunología , Inmunidad Celular , Linfocitos T/inmunología , Animales , Citomegalovirus/inmunología , Pulmón/microbiología , Ratones , Ratones Endogámicos BALB C , Glándulas Salivales/microbiología , Glándulas Salivales/patología , Bazo/citología , Bazo/inmunología , Bazo/microbiología , Factores de TiempoRESUMEN
We have constructed target cells by cotransfection of the MHC gene Ld and fragments of murine cytomegalovirus (MCMV) DNA coding for nonstructural immediate-early (IE) proteins. Transfectants were tested by using CTL clone IE1 with specificity for an IE epitope presented in association with Ld. Data show that clone IE1 recognizes a product of the ie1 transcription unit of MCMV, and that its specificity is shared by approximately 25% of polyclonal IE-specific CTL. The results provide the first definite evidence that expression of a herpes virus IE gene encoding a regulatory protein gives rise to antigen expression detectable by specific CTL.
Asunto(s)
Antígenos Virales/inmunología , Citomegalovirus/inmunología , Péptidos/inmunología , Linfocitos T Citotóxicos/inmunología , Transcripción Genética , Proteínas Virales/inmunología , Animales , Citomegalovirus/genética , ADN Viral/genética , Epítopos/inmunología , Ratones , Ratones Endogámicos BALB C , Péptidos/genética , Transfección , Proteínas Virales/genéticaRESUMEN
We have shown in a murine model system for cytomegalovirus (CMV) disease in the immunocompromised host that CMV infection interferes with the earliest detectable step in hemopoiesis, the generation of the stem cell CFU-S-I, and thereby prevents the autoreconstitution of bone marrow after sublethal irradiation. The antihemopoietic effect could not be ascribed to a direct infection of stem cells. The failure in hemopoiesis was prevented by adoptive transfer of antiviral CD8+ T lymphocytes and could be overcome by syngeneic bone marrow transplantation. CD8+ T lymphocytes and bone marrow cells both mediated survival, although only CD8+ T lymphocytes were able to limit virus multiplication in host tissues. We concluded that not the cytopathic effect of virus replication in host tissues, but the failure in hemopoiesis, is the primary cause of death in murine CMV disease.
Asunto(s)
Infecciones por Citomegalovirus/patología , Hematopoyesis , Células Madre Hematopoyéticas/patología , Síndromes de Inmunodeficiencia/complicaciones , Animales , Trasplante de Médula Ósea , Diferenciación Celular , Citomegalovirus/fisiología , Infecciones por Citomegalovirus/complicaciones , Femenino , Trasplante de Células Madre Hematopoyéticas , Inmunización Pasiva , Ratones , Ratones Endogámicos BALB C , Quimera por Radiación , Linfocitos T Reguladores/inmunología , Linfocitos T Reguladores/trasplante , Replicación ViralRESUMEN
The proteasome is a 700-kD multisubunit enzyme complex with several proteolytically active sites. The enzyme complex is involved in both ubiquitin-dependent and -independent protein degradation and may contribute to the processing of antigens presented by major histocompatibility complex (MHC) class I molecules. Here we demonstrate that treatment of mouse fibroblast cells with 20 U interferon gamma (IFN-gamma) for 3 d induces a change in the proteasome subunit composition and that the beta-type subunit LMP2, which is encoded in the MHC class II region, is incorporated into the enzyme complex. This is paralleled by reduction of the homologous delta-subunit. IFN-gamma stimulation results in a downregulation of the chymotrypsin-like Suc-LLVY-MCA peptide hydrolyzing activity of 20S proteasomes whereas the trypsin-like activity remains unaffected. When tested as a substrate a synthetic 25-mer polypeptide whose sequence covers the antigenic nonapeptide YPHFMPTNL of the MCMV pp89, 20S proteasomes of IFN-gamma-induced cells exhibit altered chymotrypsin-like cleavage site preferences. In the absence of IFN-gamma induction, the naturally processed nonamer peptide that is presented by MHC class I molecules appears as a minor cleavage product. IFN-gamma activation does not result in an increase of the final peptide but results in a different set of peptides. We hypothesize that these peptides represent precursor peptides that can be trimmed to final peptide size.
Asunto(s)
Cisteína Endopeptidasas/metabolismo , Interferón gamma/farmacología , Complejos Multienzimáticos/metabolismo , Secuencia de Aminoácidos , Animales , Cromatografía Líquida de Alta Presión , Quimotripsina/metabolismo , Células Clonales , Cisteína Endopeptidasas/efectos de los fármacos , Cisteína Endopeptidasas/aislamiento & purificación , Embrión de Mamíferos , Fibroblastos/efectos de los fármacos , Fibroblastos/enzimología , Immunoblotting , Cinética , Sustancias Macromoleculares , Ratones , Ratones Endogámicos , Datos de Secuencia Molecular , Peso Molecular , Complejos Multienzimáticos/efectos de los fármacos , Complejos Multienzimáticos/aislamiento & purificación , Fragmentos de Péptidos/química , Fragmentos de Péptidos/aislamiento & purificación , Péptidos/síntesis química , Péptidos/metabolismo , Complejo de la Endopetidasa Proteasomal , Proteínas , Especificidad por SustratoRESUMEN
Both human cytomegaloviruses (HCMVs) and murine cytomegaloviruses (MCMVs) encode multiple genes that interfere with antigen presentation by major histocompatibility complex (MHC) class I, and thus protect infected targets from lysis by virus-specific cytotoxic T lymphocytes (CTLs). HCMV has been shown to encode four such genes and MCMV to encode two. MCMV m152 blocks the export of class I from a pre-Golgi compartment, and MCMV m6 directs class I to the lysosome for degradation. A third MCMV gene, m4, encodes a glycoprotein which is expressed at the cell surface in association with class I. Here we here show that m4 is a CTL-evasion gene which, unlike previously described immune-evasion genes, inhibited CTLs without blocking class I surface expression. m152 was necessary to block antigen presentation to both K(b)- and D(b)-restricted CTL clones, while m4 was necessary to block presentation only to K(b)-restricted clones. m152 caused complete retention of D(b), but only partial retention of K(b), in a pre-Golgi compartment. Thus, while m152 effectively inhibited D(b)-restricted CTLs, m4 was required to completely inhibit K(b)-restricted CTLs. We propose that cytomegaloviruses encode multiple immune-evasion genes in order to cope with the diversity of class I molecules in outbred host populations.
Asunto(s)
Presentación de Antígeno , Genes Virales , Muromegalovirus/genética , Muromegalovirus/inmunología , Proteínas Virales/inmunología , Animales , Proteínas Portadoras/genética , Proteínas Portadoras/inmunología , Células Clonales/inmunología , Citotoxicidad Inmunológica , Glicoproteínas/genética , Glicoproteínas/inmunología , Antígenos H-2/inmunología , Antígeno de Histocompatibilidad H-2D , Antígenos de Histocompatibilidad Clase I/inmunología , Glicoproteínas de Membrana/genética , Glicoproteínas de Membrana/inmunología , Ratones , Linfocitos T CitotóxicosRESUMEN
Two populations of cytolytic T lymphocytes (CTL) generated after influenza A virus infection can be distinguished into one with specificity for the sensitizing hemagglutinin type and a second with cross-reactivity for antigens induced by other type-A influenza viruses. The molecules carrying the antigenic determinants recognized by the cross-reactive CTL were studied. In L-929 cells abortively infected with fowl plague virus, matrix (M) protein synthesis is specifically inhibited, whereas the envelope glycoproteins, hemagglutinin and neuraminidase, are synthesized and incorporated into the plasma membrane. These target cells were lysed by cross-reactive CTL. The envelope proteins of type A/Victoria virus were separated from the other virion components and reconstituted into lipid vesicles that lacked M protein that subsequently were used to prepare artificial target cells. Target-cell formation with vesicles was achieved by addition of fusion-active Sendai virus. These artificial target cells were also susceptible to lysis by cross-reactive CTL. In contrast to previous observations that suggested that the M protein of influenza viruses is recognized by these effector cells, we present evidence that the antigencic determinants induced by the viral glycoproteins are recognized.
Asunto(s)
Antígenos Virales/análisis , Citotoxicidad Inmunológica , Virus de la Influenza A/inmunología , Linfocitos T/inmunología , Proteínas Virales/inmunología , Animales , Reacciones Cruzadas , Epítopos , Glicoproteínas/inmunología , Hemaglutininas Virales , Liposomas , Proteínas de la Membrana/inmunología , Ratones , Neuraminidasa/inmunologíaRESUMEN
Proteasomes generate peptides bound by major histocompatibility complex (MHC) class I molecules. Avoiding proteasome inhibitors, which in most cases do not distinguish between individual active sites within the cell, we used a molecular genetic approach that allowed for the first time the in vivo analysis of defined proteasomal active sites with regard to their significance for antigen processing. Functional elimination of the delta/low molecular weight protein (LMP) 2 sites by substitution with a mutated inactive LMP2 T1A subunit results in reduced cell surface expression of the MHC class I H-2Ld and H-2Dd molecules. Surface levels of H-2Ld and H-2Dd molecules were restored by external loading with peptides. However, as a result of the active site mutation, MHC class I presentation of a 9-mer peptide derived from a protein of murine cytomegalovirus was enhanced about three- to fivefold. Our experiments provide evidence that the delta/LMP2 active site elimination limits the processing and presentation of several peptides, but may be, nonetheless, beneficial for the generation and presentation of others.
Asunto(s)
Presentación de Antígeno , Antígenos Virales/inmunología , Cisteína Endopeptidasas/inmunología , Antígenos de Histocompatibilidad Clase I/inmunología , Complejos Multienzimáticos/inmunología , Muromegalovirus/inmunología , Animales , Sitios de Unión/inmunología , Línea Celular , Ratones , Ratones Endogámicos BALB C , Complejo de la Endopetidasa ProteasomalRESUMEN
Virus shedding from the epithelial cells of the serous acini of salivary glands is a major source for the horizontal transmission of cytomegalovirus. These cells are, different to other tissues, exempt from CD8 T lymphocyte control. CD4 T lymphocytes are essential to terminate the productive infection. Here, we prove that T-B cooperation and the production of antibodies are not required for this process. For the infection with murine cytomegalovirus, mutant mice were used which do not produce antibodies because of a disrupted membrane exon of the immunoglobulin mu chain gene. Also, in these mice the virus clearance from salivary glands is a function of CD4 T lymphocytes. However, these mice clear the virus and establish viral latency with a kinetics that is distinguishable from normal mice. Reactivation from virus latency is the only stage at which the absence of antibodies alters the phenotype of infection. In immunoglobulin-deficient mice, virus recurrence results in higher virus titers. The adoptive serum transfer proved that antibody is the limited factor that prevents virus dissemination in the immunodeficient host.
Asunto(s)
Anticuerpos Antivirales/inmunología , Infecciones por Citomegalovirus/inmunología , Citomegalovirus/inmunología , Animales , Citomegalovirus/fisiología , Infecciones por Citomegalovirus/transmisión , Femenino , Terapia de Inmunosupresión , Masculino , Ratones , Ratones Endogámicos C57BL , Recurrencia , Replicación Viral/inmunología , Esparcimiento de VirusRESUMEN
Recurrence of cytomegalovirus (CMV) from latency is a frequent cause of disease in immunocompromised patients. To date, there is no explanation for the diversity in the clinical manifestations. Primary infection can occur perinatally or later in life, and inevitably results in latent infection. Seropositivity for antibodies against CMV is indicative of latent infection, but is insufficient as a predictor for the risk of recurrence. As a model for this important medical problem, we compared the risks of murine CMV recurrence from latency established after neonatal primary infection and after infection at adult age. The risk of CMV recurrence was high only after neonatal infection. The copy number of latent viral genome in tissues was identified as the key parameter that determines the overall and organ-specific risks of recurrence. Latent CMV burden and risk of recurrence were related to the extent of virus multiplication during primary infection. The presence of latent CMV in multiple organs provides the molecular basis for stochastic events of recurrence in single organs or in any combination thereof. These findings are discussed as a concept of multifocal CMV latency and recurrence. It provides a rationale for the diversity in the clinical outcome of CMV disease.
Asunto(s)
Infecciones por Citomegalovirus/microbiología , Citomegalovirus/fisiología , ADN Viral/aislamiento & purificación , Latencia del Virus , Animales , Anticuerpos Antivirales/sangre , Citomegalovirus/genética , Citomegalovirus/aislamiento & purificación , Infecciones por Citomegalovirus/inmunología , Modelos Animales de Enfermedad , Femenino , Genoma Viral , Humanos , Pulmón/microbiología , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Pruebas de Neutralización , Recurrencia , Glándulas Salivales/microbiología , Bazo/microbiologíaRESUMEN
Proteasomes degrade endogenous proteins in the cytosol. The potential contribution of the proteasome to the effect of flanking sequences on the presentation of an antigenic epitope presented by the major histocompatibility complex class I allele Ld was studied. Peptides generated in cells from minigenes coding for peptides of 17- and 19-amino acid length were compared with the in vitro 20S proteasome degradation products of the respective synthetic peptides. The quality of generated peptides was independent of ubiquitination. In vivo and in vitro processing products were indistinguishable with respect to peptide size and abundance. Altering the neighboring sequence substantially improved the yield of the final antigenic nonapeptide by 20S proteasome cleavage. These results suggest that, in addition to the presence of major histocompatibility complex class I allelic motifs, the cleavage preference of the proteasome can define the antigenic potential of a protein.
Asunto(s)
Células Presentadoras de Antígenos/metabolismo , Cisteína Endopeptidasas/metabolismo , Complejos Multienzimáticos/metabolismo , Péptidos/inmunología , Aldehídos , Secuencia de Aminoácidos , Animales , Antígenos Virales/química , Células Cultivadas , Citomegalovirus/inmunología , Mapeo Epitopo , Espectrometría de Masas , Ratones , Ratones Endogámicos BALB C , Datos de Secuencia Molecular , Péptidos/química , Péptidos/metabolismo , Complejo de la Endopetidasa Proteasomal , Proteínas Recombinantes , Relación Estructura-Actividad , Especificidad por Sustrato , Linfocitos T Citotóxicos/inmunología , Ubiquitinas/metabolismoRESUMEN
Cytomegaloviruses encode numerous functions that inhibit antigen presentation in the major histocompatibility complex (MHC) class I pathway in vitro. One example is the mouse cytomegalovirus (MCMV) glycoprotein gp40, encoded by the m152 gene, which selectively retains murine but not human MHC class I complexes in the endoplasmic reticulum-Golgi intermediate compartment/cis-Golgi compartment (Ziegler, H., R. Thäle, P. Lucin, W. Muranyi, T. Flohr, H. Hengel, H. Farrell, W. Rawlinson, and U.H. Koszinowski. 1997. Immunity. 6:57-66). To investigate the in vivo significance of this gene function during MCMV infection of the natural host, we constructed recombinants of MCMV in which the m152 gene was deleted, as were the corresponding virus revertants. We report on the following findings: Deletion of the m152 gene has no effect on virus replication in cell culture, whereas after infection of mice, the m152-deficient virus replicates to significantly lower virus titers. This attenuating effect is lifted by reinsertion of the gene into the mutant. Mutants and revertants grow to the same titer in animals deprived of the function targeted by the viral gene function, namely in mice deficient in beta2-microglobulin, mice deficient in the CD8 molecule, and mice depleted of T cells. Upon adoptive transfer of naive lymphocytes into infected mice, the absence of the m152 gene function sensitizes the virus to primary lymphocyte control. These results prove that MHC-reactive functions protect CMVs against attack by CD8(+) T lymphocytes in vivo.
Asunto(s)
Glicoproteínas de Membrana/genética , Linfocitos T/metabolismo , Células 3T3 , Animales , Presentación de Antígeno/inmunología , Linfocitos T CD8-positivos/inmunología , Pruebas Inmunológicas de Citotoxicidad , Eliminación de Gen , Genes MHC Clase I/inmunología , Inmunidad , Glicoproteínas de Membrana/inmunología , Ratones , Ratones Endogámicos , Mutación , Proteínas Virales/inmunología , Virulencia , Replicación ViralRESUMEN
Reactivation from latent cytomegalovirus (CMV) infection is often associated with conditions of immunosuppression and can result in fatal disease. Whether the maintenance of systemic CMV latency is mainly governed by factors of the infected cell or by immune control functions is unknown. Likewise, the putative immune control mechanisms which could prevent the induction and spread of recurrent CMV infection are not clearly identified. We took advantage of latently infected B cell-deficient mice and a sensitive method for virus detection to study CMV reactivation after ablation of lymphocyte subsets. A crucial role of both T lymphocytes and natural killer (NK) cells was demonstrated. Within 5 d after depletion of lymphocytes, productive infection occurred in 50% of mice, and 14 d later 100% of mice exhibited recurrent infection. A hierarchy of immune control functions of CD8(+), NK, and CD4(+) cells was established. Reactivation was rare if only one of the lymphocyte subsets was depleted, but was evident after removal of a further subset, indicating a functional redundancy of control mechanisms. The salivary glands were identified as the site of most rapid virus shedding, followed by the detection of recurrent virus in the lungs, and eventually in the spleen. Our findings document a previously unknown propensity of latent CMV genomes to enter productive infection immediately and with a high frequency after immune cell depletion. The data indicate that only the sustained cellular immune control prevents CMV replication and restricts the viral genome to a systemic state of latency.
Asunto(s)
Infecciones por Citomegalovirus/inmunología , Citomegalovirus/fisiología , Subgrupos Linfocitarios/inmunología , Latencia del Virus/fisiología , Replicación Viral/fisiología , Animales , Citomegalovirus/aislamiento & purificación , Infecciones por Citomegalovirus/genética , Infecciones por Citomegalovirus/virología , Síndromes de Inmunodeficiencia/genética , Síndromes de Inmunodeficiencia/virología , Interferón gamma/fisiología , Células Asesinas Naturales/inmunología , Depleción Linfocítica , Ratones , Ratones Endogámicos BALB C , Ratones Mutantes , Especificidad de Órganos , Recurrencia , Subgrupos de Linfocitos T/inmunologíaRESUMEN
Selective expression of murine cytomegalovirus (MCMV) immediate-early (IE) genes leads to the presentation by the major histocompatibility complex (MHC) class I molecule Ld of a peptide derived from MCMV IE protein pp89 (Reddehase, M.J., J. B. Rothbard, and U.H. Koszinowski. 1989. Nature (Lond.). 337:651). Characterization of endogenous antigenic peptides identified the pp89 peptide as the nonapeptide 168YPHFMPTNL176 (del Val, M., H.-J. Schlicht, T. Ruppert, M.J. Reddehase, and U.H. Koszinowski. 1991. Cell. 66:1145). Subsequent expression of MCMV early genes prevents presentation of pp89 (del Val, M., K. Münch, M.J. Reddehase, and U.H. Koszinowski. 1989. Cell. 58:305). We report on the mechanism by which MCMV early genes interfere with antigen presentation. Expression of the IE promoter-driven bacterial gene lacZ by recombinant MCMV subjected antigen presentation of beta-galactosidase to the same control and excluded antigen specificity. The Ld-dependent presence of naturally processed antigenic peptides also in nonpresenting cells located the inhibitory function subsequent to the step of antigen processing. The finding that during the E phase of MCMV gene expression the MHC class I heavy chain glycosylation remained in an Endo H-sensitive form suggested a block within the endoplasmic reticulum/cis-Golgi compartment. The failure to present antigenic peptides was explained by a general retention of nascent assembled trimolecular MHC class I complexes. Accordingly, at later stages of infection a significant decrease of surface MHC class I expression was seen, whereas other membrane glycoproteins remained unaffected. Thus, MCMV E genes endow this virus with an effective immune evasion potential. These results also indicate that the formation of the trimolecular complex of MHC class I heavy chain, beta 2-microglobulin, and the finally trimmed peptide is completed before entering the medial-Golgi compartment.
Asunto(s)
Células Presentadoras de Antígenos/inmunología , Antígenos Virales/inmunología , Citomegalovirus/inmunología , Aparato de Golgi/inmunología , Proteínas Inmediatas-Precoces , Complejo Mayor de Histocompatibilidad/inmunología , Secuencia de Aminoácidos , Animales , Células Presentadoras de Antígenos/microbiología , Transporte Biológico , Línea Celular , Citomegalovirus/genética , Ratones , Ratones Endogámicos BALB C , Datos de Secuencia Molecular , Pruebas de Precipitina , Procesamiento Proteico-Postraduccional , Mapeo RestrictivoRESUMEN
A high proportion of tumors arise due to mutation of the p53 tumor suppressor protein. A p53 hotspot mutation at amino acid position 273 from R to H, flanking a peptide epitope that spans residues 264-272, renders cells resistant to killing by human histocompatibility leukocyte antigen (HLA)-A*0201-restricted cytotoxic T lymphocytes (CTLs) specific for this epitope. Acquisition of the R to H mutation at residue 273 of the human p53 protein promotes tumor growth in vivo by selective escape from recognition by p53.264-272 peptide-specific CTLs. Synthetic 27-mer p53 polypeptides covering the antigenic nonamer region 264-272 of p53 were used as proteasome substrates to investigate whether the R to H mutation at the P1' position of the COOH terminus of the epitope affects proteasome-mediated processing of the protein. Analysis of the generated products by tandem mass spectrometry and the kinetics of polypeptide processing in conjunction with CTL assays demonstrate that the R to H mutation alters proteasomal processing of the p53 protein by inhibiting proteolytic cleavage between residues 272 and 273. This prevents the release of the natural CTL epitope that spans flanking residues 264-272 as well as a putative precursor peptide. These results demonstrate that mutation of p53 not only leads to malignant transformation but may also, in some instances, affect immune surveillance and should be considered in the design of cancer vaccines.
Asunto(s)
Citotoxicidad Inmunológica/genética , Epítopos de Linfocito T/inmunología , Mutación Puntual/inmunología , Linfocitos T Citotóxicos/inmunología , Proteína p53 Supresora de Tumor/genética , Secuencia de Aminoácidos , Animales , Presentación de Antígeno/genética , Arginina/genética , Sitios de Unión/genética , Sitios de Unión/inmunología , División Celular/genética , División Celular/inmunología , Cisteína Endopeptidasas/metabolismo , Pruebas Inmunológicas de Citotoxicidad , Antígenos HLA-A/inmunología , Antígenos HLA-A/metabolismo , Histidina/genética , Humanos , Hidrólisis , Ratones , Ratones Transgénicos , Datos de Secuencia Molecular , Complejos Multienzimáticos/metabolismo , Fragmentos de Péptidos/genética , Fragmentos de Péptidos/inmunología , Fragmentos de Péptidos/metabolismo , Péptidos/síntesis química , Péptidos/inmunología , Péptidos/metabolismo , Complejo de la Endopetidasa Proteasomal , Especificidad por Sustrato/genética , Especificidad por Sustrato/inmunología , Células Tumorales CultivadasRESUMEN
Bacterial artificial chromosomes (BACs) are DNA molecules assembled in vitro from defined constituents and are stably maintained as one large DNA fragment in Escherichia coli. Artificial chromosomes are useful for genome sequencing programs, for transduction of DNA segments into eukaryotic cells, and for functional characterization of genomic regions and entire viral genomes such as cytomegalovirus (CMV) genomes. CMV genomes in BACs are ready for the advanced tools of E. coli genetics. Homologous and site-specific recombination, or transposon-based approaches allow for the engineering of virtually any kind of genetic change.
Asunto(s)
Citomegalovirus/genética , Genoma Viral , Cromosomas Artificiales Bacterianos , Escherichia coli/genética , Mutagénesis Insercional , Mutagénesis Sitio-Dirigida , Recombinación GenéticaRESUMEN
Human cytomegalovirus infects vascular tissues and has been associated with atherogenesis and coronary restenosis. Although established laboratory strains of human cytomegalovirus have lost the ability to grow on vascular endothelial cells, laboratory strains of murine cytomegalovirus retain this ability. With the use of a forward-genetic procedure involving random transposon mutagenesis and rapid phenotypic screening, we identified a murine cytomegalovirus gene governing endothelial cell tropism. This gene, M45, shares sequence homology to ribonucleotide reductase genes. Endothelial cells infected with M45-mutant viruses rapidly undergo apoptosis, suggesting that a viral strategy to evade destruction by cellular apoptosis is indispensable for viral growth in endothelial cells.
Asunto(s)
Endotelio Vascular/citología , Endotelio Vascular/virología , Genes Virales , Muromegalovirus/genética , Muromegalovirus/fisiología , Ribonucleótido Reductasas/genética , Proteínas Virales , Células 3T3 , Animales , Apoptosis , Secuencia de Bases , Línea Celular , Efecto Citopatogénico Viral , Elementos Transponibles de ADN , Fibroblastos/virología , Mutación del Sistema de Lectura , Biblioteca de Genes , Ratones , Datos de Secuencia Molecular , Muromegalovirus/crecimiento & desarrollo , Mutagénesis Insercional , Sistemas de Lectura Abierta , Fenotipo , Ribonucleótido Reductasas/fisiología , Replicación ViralRESUMEN
The large, complex genomes of herpesviruses document the high degree of adaptation of these viruses to their hosts. Not surprisingly, the methods developed over the past 30 years to analyse herpesvirus genomes have paralleled those used to investigate the genetics of eukaryotic cells. The recent use of bacterial artificial chromosome (BAC) technology in herpesvirus genetics has made their genomes accessible to the tools of bacterial genetics. This has opened up new avenues for reverse and forward genetics of this virus family in basic research, and also for vector and vaccine development.
Asunto(s)
Cromosomas Bacterianos , Técnicas Genéticas , Herpesviridae/genética , Mutagénesis , Alelos , Elementos Transponibles de ADN , Predicción , Genoma ViralRESUMEN
Viruses that establish persistent infections in their host, such as herpesviruses, adenoviruses or HIV, express proteins designed to pre-empt or evade recognition and elimination by MHC class I restricted CD8+ T lymphocytes. Notable discoveries during the annual period of review have demonstrated that, in principle, each single step within the MHC class I pathway of antigen processing and presentation is fair game for manipulation by viral functions. The viral factors that are natural inhibitors of this pathway have been instrumental for the elucidation of the distinct molecular mechanisms that are exploited by viruses. The viral stealth strategies that downregulate MHC class I protein surface expression may lead, however, to a higher susceptibility of virus-infected cells to natural killer cell activity. Strikingly, there is evidence that some viruses counteract increased natural killer cell recognition by expressing viral MHC class I homologues that function as surrogate inhibitors of natural killer cell activity.